Depressie en angststoornissen Depression and anxiety
Conditions
Interventions
Antidepressants:
Subjects will receive standardized treatment with selective serotonin reuptake inhibitor (SSRI) which has documented efficacy, a rather favorable side effect profile, is recommended
Sponsors
B.W.J.H. Penninx, GGZ inGeest/ VUmc
Eligibility
Inclusion criteria
Inclusion criteria: Current depressive disorder or a current anxiety disorder as ascertained by the DSM-IV criteria.
Exclusion criteria
Exclusion criteria: 1. Current use of antidepressants (antidepressants have to be eliminated for at least four weeks for participation of this study); 2. Current use of psychotropic medication, except for the use of benzodiazepine for which dosage has to be constant; 3. Ongoing participation in regular (>1/week) exercise; 4. Primary severe, clinically diagnosed psychiatric diagnosis other than a depressive or anxiety disorder (bipolar disorder, psychosis, addictive disorder); 5. Evidence of acute suicidal risk; 6. Medical contra-indications to exercise or antidepressants (current heart problems) as confirmed by a physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in physical health after antidepressants or runningtherapy, especially in metabolic syndrom and cellular aging. | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparability of the effectivity of antidepressants and running in reduction of metabolic syndrom and cellular aging. | — |
Contacts
Public ContactB. Lever- van Milligen
A.J. Ernststraat 1187
Outcome results
None listed